US Stock MarketDetailed Quotes

KRON Kronos Bio

Watchlist
  • 0.790
  • +0.009+1.15%
Close May 31 16:00 ET
47.47MMarket Cap-396P/E (TTM)

About Kronos Bio Company

Kronos Bio, Inc. is a clinical development biopharmaceutical company. It engages in the business of developing therapeutics that target dysregulated transcription that causes cancer and other serious diseases. The company was founded by Arie S. Belldegrun, Joshua A. Kazam, David M. Tanen, and Christopher Wilfong on June 2, 2017 and is headquartered in San Mateo, CA.

Company Profile

SymbolKRON
Company NameKronos Bio
Listing DateOct 9, 2020
Issue Price19.00
Founded2017
CEOProfessor Dr. Norbert W. Bischofberger, PhD
MarketNASDAQ
Employees62
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1300 So. El Camino Real,Suite 300
CitySan Mateo
ProvinceCalifornia
CountryUnited States of America
Zip Code94402
Phone1-650-781-5200

Company Executives

  • Name
  • Position
  • Salary
  • Professor Dr. Norbert W. Bischofberger, PhD
  • Director, President and Chief Executive Officer
  • 1.76M
  • Sandra A. Gardiner
  • Principal Accounting Officer and Interim Chief Financial Officer
  • --
  • Charles Y. Lin, PhD
  • Senior Vice President, Research and Development
  • --
  • Dr. Elizabeth A. Olek, D.O.,M.P.H.
  • Senior Vice President, Clinical Development
  • --
  • Allison Frisbee, J.D.
  • Senior Vice President, Corporate Operations and Legal
  • --
  • Dr. Arie S. Belldegrun, F.A.C.S.,M.D.
  • Chairman of the Board
  • 117.20K
  • David M. Tanen
  • Director
  • 74.80K
  • Joshua A. Kazam
  • Director
  • 74.80K
  • Dr. Taiyin Yang, PhD
  • Independent Director
  • 88.70K
  • Dr. Roger D. Dansey, M.D.
  • Independent Director
  • 97.52K
  • Elena H. Ridloff, C.F.A.
  • Independent Director
  • 89.17K
  • Katherine Vega Stultz
  • Independent Director
  • 105.68K
  • Roshawn A. Blunt
  • Independent Director
  • 79.80K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg